NCT01129102View on ClinicalTrials.gov

Efficacy and Safety Study of NPC-01 to Treat Dysmenorrhea

PHASE3CompletedINTERVENTIONAL
Enrollment

215

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Dysmenorrhea
Interventions
DRUG

NPC-01

Norethisterone 1mg, Ethinyl estradiol 0.02mg

DRUG

IKH-01

Norethisterone 1mg, Ethinyl estradiol 0.035mg

DRUG

Placebo

Placebo for NPC-01

Sponsors

Lead Sponsor

Nobelpharma
All Listed Sponsors
lead

Nobelpharma

INDUSTRY

NCT01129102 - Efficacy and Safety Study of NPC-01 to Treat Dysmenorrhea | Biotech Hunter | Biotech Hunter